The FDA's proposed rule on laboratory-developed tests: what happens next?

JR Genzen, KA Moser - Laboratory Medicine, 2024 - academic.oup.com
On December 4, 2023, the public comment period for the US Food and Drug
Administration's(FDA) proposed rule to regulate laboratory-developed tests (LDTs) as …

The FDA's Proposed Rule on Laboratory-Developed Tests: Impacts on Clinical Laboratories and Patient Care

L Smith, LA Carricaburu, JR Genzen - 2024 - europepmc.org
In October 2023, the US Food and Drug Administration (FDA) released a proposed rule to
regulate laboratory-developed tests (LDTs) as medical devices. While approximately 6,700 …

The FDA's Proposed Rule on Laboratory-Developed Tests: Impacts on Clinical Laboratory Testing and Patient Care

L Smith, LA Carricaburu, JR Genzen - medRxiv, 2024 - medrxiv.org
ABSTRACT In October 2023, the US Food and Drug Administration (FDA) released a
proposed rule to regulate laboratory-developed tests (LDTs) as medical devices. While …

FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories?

MG Scott, ER Ashwood, TM Annesley… - Clinical …, 2013 - academic.oup.com
In 2010 the US Food and Drug Administration (FDA) 7 stated that it would issue guidance on
its oversight of laboratory-developed tests (LDTs), and in July of that year the FDA held a …

Infrastructure Limitations of US Food and Drug Administration Proposed Review of Laboratory-Developed Tests

DH Tacker, JR Wiencek - The Journal of Applied Laboratory …, 2024 - academic.oup.com
* Address correspondence to this author at: Department of Pathology, Microbiology, and
Immunology, Vanderbilt University School of Medicine, 1301 Medical Center Drive, 4605 …

[HTML][HTML] The US FDA's Proposed Rule on Laboratory-Developed Tests: Impacts on Clinical Laboratory Testing

L Smith, LA Carricaburu, JR Genzen - Practical Laboratory Medicine, 2024 - Elsevier
Objectives To solicit quantifiable feedback from clinical laboratorians on the US Food and
Drug Administration (FDA) proposed rule to regulate laboratory-developed tests (LDTs) as …

Counterpoint: Why the FDA Should Not Regulate Laboratory-Developed Tests

ML Leung - The journal of applied laboratory medicine, 2024 - academic.oup.com
January 2024| 09: 01| 155–158| JALM 155 results could lead to patient harm, many of these
claims are based on potential inappropriate actions by providers interpreting test results and …

FDA's proposed rule for the regulation of laboratory-developed tests

MB Miller, ML Watts, L Samuel - Journal of clinical microbiology, 2024 - Am Soc Microbiol
ABSTRACT In October 2023, the Food and Drug Administration (FDA) released a proposed
rule that ends enforcement discretion for laboratory-developed tests (LDTs). The FDA's …

Fundamental Uncertainty: Interplatform Inconsistency of FDA-Cleared Serological Tests

MA Cervinski - The Journal of Applied Laboratory Medicine, 2024 - academic.oup.com
Although the VALID act failed to advance through Congress and become law in early 2023,
it was disappointing to see a new attempt by the US FDA to change the regulatory paradigm …

Public Perspectives on Direct-to-Consumer Testing Oversight

S Jiang, D Lebo, T Schultz - Therapeutic Innovation & Regulatory Science, 2024 - Springer
The FDA published a final rule for Medical Devices; Laboratory Developed Tests in the
Federal Register on May 6, 2024, which aims to ensure the safety and effectiveness of …